…and suggest that formal remission does not always coincide with GC withdrawal. Personalized management remains essential to optimi…
GC
This drug is selected. Its supporting articles are shown below.
Articles mentioning GC
9 articles · page 1 of 1…uppressants (off-treatment; n = 244), AM monotherapy (n = 198), GC monotherapy (n = 45), or AM and GC combined therapy but no immu…
…ater cumulative time in LLDAS over 12 months is achieved in the rituximab group compared with placebo. We will also evaluate secondary ou…
…d HCQ 400 mg/day. In August 2025, due to inadequate efficacy of rituximab (3 g), intolerance to MMF, and limitations on IS (due to leukop…
…in systemic lupus erythematosus (SLE) and different patterns of glucocorticoid (GC) dosing.Methods We studied a nationwide cohort of individua…
…3), organ damage (SLICC/ACR Damage Index) (SDI), treatments and prednisone dosages for every visit were collected.We compared patients nev…
… frequently experience inadequate responses to glucocorticoids (GC) and immunosuppressants (IS), leading to refractory disease and…
…tment escalation, including GC, azathioprine (150 mg/daily) and hydroxychloroquine (400 mg/daily). However, only hemoglobin levels improved, while…
…licated autoimmune disease characterized by recurrent relapses. Belimumab (BEL) is a humanized monoclonal antibody and has been approved …